Via The Lancet: CEPI—a new global R&D organisation for epidemic preparedness and response. Excerpt:
In January, 2016, the World Economic Forum convened a group of representatives to explore the way forward, with vaccine development as the starting focus. The Ebola epidemic had shown that fast-track and collaborative development of vaccines was possible. More than 15 clinical vaccine trials (phase 1, 2, and 3) were planned and implemented within a year from August, 2014, and the ring vaccination trial in Guinea showed effectiveness of the replication-competent recombinant vesicular stomatitis virus (rVSV) vectored vaccine for the prevention of Ebola virus disease in interim and final reports.
Now global efforts are also focused on Zika virus, another epidemic declared by WHO as a Public Health Emergency of International Concern between February, 2016, and November, 2016. Vaccine development has been initiated and several candidates have entered initial clinical testing.
During the World Economic Forum meeting a consensus emerged on the need for a new approach to public–private collaboration to address epidemics and for exploring the establishment of a new financing mechanism.
Now, CEPI—the Coalition for Epidemic Preparedness Innovations, a partnership between public, private, philanthropic, non-governmental, intergovernmental, and civil organisations, is launched on Jan 19 at the World Economic Forum's 2017 meeting.
CEPI will be based in Oslo, Norway, with offices in the UK, India, and the USA, but will be a global organisation with partners on all continents. CEPI provides a new funding model for the development of vaccines against epidemic infectious diseases through pooling resources from several investors. This coalition will build a new system to advance the development of safe, effective, and affordable vaccines, ensuring that price is not a barrier to access for populations most at need.
This will offer the world an insurance policy against the growing threat from emerging infectious diseases. CEPI will fill the gap between the normative functions of WHO and the procurement and delivery mandate of Gavi, the Vaccine Alliance, and close an important gap in global health architecture.